We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CZFS:NASDAQCitizens Financial Services, Inc. Analysis

Data as of 2026-06-18 - not real-time

$66.45

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Citizens Financial Services (CZFS) appears markedly undervalued with a price-to-earnings multiple that sits comfortably below the industry norm, while its price‑to‑book ratio is under one, indicating a discount to book value. The bank’s dividend yield is attractive for income‑focused investors, and the payout ratio remains modest, supporting sustainability. Revenue growth is solid and operating margins are healthy, delivering strong profitability metrics. The balance sheet shows ample cash relative to debt and a low beta, suggesting limited market‑wide volatility exposure.
Technical indicators reinforce the upside narrative: the 20‑day and 50‑day moving averages sit above the 200‑day average, the MACD line is bullish, and price is trading above a clear support level while still below the 52‑week high. Volume trends are stable, and the market sentiment index reflects extreme greed, hinting at bullish investor appetite. Combined, these fundamentals and technicals point to a compelling entry point with upside potential, especially given the sizeable gap between the current price and the discounted cash‑flow fair value estimate.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical setup with price above short‑term averages
  • Support level holding firm
  • Stable trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Attractive dividend yield with low payout ratio
  • Continued revenue growth and strong operating margins

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Fundamental strength of a regional bank with low beta
  • Sustainable dividend stream
  • Long‑term upside potential as the market re‑prices the undervaluation

Key Metrics & Analysis

Financial Health

Revenue Growth13.60%
Profit Margin34.66%
P/E Ratio8.1
ROE12.07%
ROA1.30%
P/B Ratio0.9
Op. Cash Flow$43.6M
Industry P/E17.1

Technical Analysis

TrendBullish
RSI53.0
Support$62.60
Resistance$71.85
MA 20$65.68
MA 50$65.41
MA 200$61.20
MACDBullish
VolumeStable
Fear & Greed Index88.5

Valuation

Fair Value$115.80
Target Price$71.00
Upside/Downside6.85%
GradeUndervalued
TypeBlend
Dividend Yield3.08%

Risk Assessment

Beta0.41
Volatility29.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.